vs
爱德华生命科学（EW）与希捷科技（STX）财务数据对比。点击上方公司名可切换其他公司
希捷科技的季度营收约是爱德华生命科学的1.9倍（$3.1B vs $1.6B），希捷科技净利率更高（24.0% vs 23.1%，领先0.9%），希捷科技同比增速更快（44.1% vs 16.7%），过去两年希捷科技的营收复合增速更高（28.4% vs 9.7%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
希捷科技是全球知名的美国数据存储企业，1978年注册成立时名为舒加特科技，1979年正式开展业务，2010年起注册地变更为爱尔兰都柏林，运营总部设在美国加利福尼亚州弗里蒙特，面向全球市场提供专业的数据存储产品与解决方案。
EW vs STX — 直观对比
营收规模更大
STX
是对方的1.9倍
$1.6B
营收增速更快
STX
高出27.4%
16.7%
净利率更高
STX
高出0.9%
23.1%
两年增速更快
STX
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $3.1B |
| 净利润 | $380.7M | $748.0M |
| 毛利率 | 78.0% | 46.5% |
| 营业利润率 | 1.8% | 32.1% |
| 净利率 | 23.1% | 24.0% |
| 营收同比 | 16.7% | 44.1% |
| 净利润同比 | 6.8% | -23.8% |
| 每股收益（稀释后） | $0.66 | $3.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWSTX
| Q3 26 | — | $3.1B | ||
| Q1 26 | $1.6B | $2.8B | ||
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.5B | $2.4B | ||
| Q1 25 | $1.4B | $2.2B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.4B | $2.2B |
净利润EWSTX
| Q3 26 | — | $748.0M | ||
| Q1 26 | $380.7M | $593.0M | ||
| Q4 25 | $91.2M | $549.0M | ||
| Q3 25 | $291.1M | — | ||
| Q2 25 | $333.2M | $488.0M | ||
| Q1 25 | $358.0M | $340.0M | ||
| Q4 24 | $385.6M | $336.0M | ||
| Q3 24 | $3.1B | $305.0M |
毛利率EWSTX
| Q3 26 | — | 46.5% | ||
| Q1 26 | 78.0% | 41.6% | ||
| Q4 25 | 78.1% | 39.4% | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | 37.4% | ||
| Q1 25 | 78.7% | 35.2% | ||
| Q4 24 | 78.9% | 34.9% | ||
| Q3 24 | 80.6% | 32.9% |
营业利润率EWSTX
| Q3 26 | — | 32.1% | ||
| Q1 26 | 1.8% | 29.8% | ||
| Q4 25 | 9.6% | 26.4% | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 26.8% | 23.2% | ||
| Q1 25 | 27.9% | 20.0% | ||
| Q4 24 | 22.6% | 21.0% | ||
| Q3 24 | 25.9% | 18.6% |
净利率EWSTX
| Q3 26 | — | 24.0% | ||
| Q1 26 | 23.1% | 21.0% | ||
| Q4 25 | 5.8% | 20.9% | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 21.7% | 20.0% | ||
| Q1 25 | 25.3% | 15.7% | ||
| Q4 24 | 27.8% | 14.5% | ||
| Q3 24 | 226.7% | 14.1% |
每股收益（稀释后）EWSTX
| Q3 26 | — | $3.27 | ||
| Q1 26 | $0.66 | $2.60 | ||
| Q4 25 | $0.16 | $2.43 | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.56 | $2.24 | ||
| Q1 25 | $0.61 | $1.57 | ||
| Q4 24 | $0.65 | $1.55 | ||
| Q3 24 | $5.13 | $1.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1B |
| 总债务越低越好 | — | $3.9B |
| 股东权益账面价值 | — | — |
| 总资产 | — | $8.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EWSTX
| Q3 26 | — | $1.1B | ||
| Q1 26 | — | $1.0B | ||
| Q4 25 | $4.2B | $1.1B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $4.1B | $891.0M | ||
| Q1 25 | $3.9B | $814.0M | ||
| Q4 24 | $4.0B | $1.2B | ||
| Q3 24 | $4.4B | $1.2B |
总债务EWSTX
| Q3 26 | — | $3.9B | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
股东权益EWSTX
| Q3 26 | — | — | ||
| Q1 26 | — | $459.0M | ||
| Q4 25 | $10.3B | $-63.0M | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.5B | $-453.0M | ||
| Q1 25 | $10.1B | $-829.0M | ||
| Q4 24 | $10.0B | $-1.1B | ||
| Q3 24 | $9.5B | $-1.3B |
总资产EWSTX
| Q3 26 | — | $8.9B | ||
| Q1 26 | — | $8.7B | ||
| Q4 25 | $13.7B | $8.4B | ||
| Q3 25 | $13.3B | — | ||
| Q2 25 | $13.5B | $8.0B | ||
| Q1 25 | $13.0B | $7.6B | ||
| Q4 24 | $13.1B | $8.0B | ||
| Q3 24 | $13.0B | $8.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.4B |
| 自由现金流经营现金流 - 资本支出 | — | $953.0M |
| 自由现金流率自由现金流/营收 | — | 30.6% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.17× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EWSTX
| Q3 26 | — | $2.4B | ||
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $532.0M | ||
| Q3 25 | $573.7M | — | ||
| Q2 25 | $290.2M | $508.0M | ||
| Q1 25 | $280.4M | $259.0M | ||
| Q4 24 | $-127.5M | $221.0M | ||
| Q3 24 | $351.8M | $95.0M |
自由现金流EWSTX
| Q3 26 | — | $953.0M | ||
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $427.0M | ||
| Q3 25 | $516.2M | — | ||
| Q2 25 | $240.9M | $425.0M | ||
| Q1 25 | $224.4M | $216.0M | ||
| Q4 24 | $-177.3M | $150.0M | ||
| Q3 24 | $299.9M | $27.0M |
自由现金流率EWSTX
| Q3 26 | — | 30.6% | ||
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 16.2% | ||
| Q3 25 | 33.2% | — | ||
| Q2 25 | 15.7% | 17.4% | ||
| Q1 25 | 15.9% | 10.0% | ||
| Q4 24 | -12.8% | 6.5% | ||
| Q3 24 | 22.1% | 1.2% |
资本支出强度EWSTX
| Q3 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 4.0% | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.2% | 3.4% | ||
| Q1 25 | 4.0% | 2.0% | ||
| Q4 24 | 3.6% | 3.1% | ||
| Q3 24 | 3.8% | 3.1% |
现金转化率EWSTX
| Q3 26 | — | 3.17× | ||
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | 0.97× | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 0.87× | 1.04× | ||
| Q1 25 | 0.78× | 0.76× | ||
| Q4 24 | -0.33× | 0.66× | ||
| Q3 24 | 0.11× | 0.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
